Skip to main content
Clinical Trials/NCT05924893
NCT05924893
Completed
Not Applicable

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

Minia University1 site in 1 country50 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Naltrexone Hydrochloride
Conditions
Cornea Ulcer
Sponsor
Minia University
Enrollment
50
Locations
1
Primary Endpoint
healing of ulcer
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The opioid growth factor-receptor antagonist-naltrexone hydrochloride (NTX)- has gained much reach interest for applications in ophthalmology, because of its novel mechanism of action for speeding up corneal wound healing in both diabetics and non-diabetics, effective both locally and systemically and its availability as a low molecular weight synthetic drug.

Detailed Description

Corneal epithelial defects generally heal within 2 days without complications, in some patients with decreased corneal sensitivity, such as patients with severe dry eye, corneal neuropathy, or autoimmune diseases, the corneal epithelium shows a reduced tendency for spontaneous healing Resistant corneal ulcers may appear as epithelial defects associated to Bowman's layer disruption with associated damage and partial variable loss of superficial corneal stroma larger than 2 mm in diameter that persist more than 2 weeks even treated with conventional treatment . Noninfectious corneal ulcers have a similar clinical presentation like that of infectious ulcers but with no known infectious cause . Resistant corneal ulcer can lead to serious complications such as infection, inflammation, corneal scarring, opacification, corneal thinning, and perforation . In our study NTX accelerated healing of resistant corneal ulcers that was refractory to conventional treatment with lubricant eye drops and was safe with no complications reported in all treated eyes.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 15, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Minia University
Responsible Party
Principal Investigator
Principal Investigator

Ahemd Abdelghany

Associate professor

Minia University

Eligibility Criteria

Inclusion Criteria

  • refractory non infective corneal ulcer

Exclusion Criteria

  • infection

Arms & Interventions

Naltrexone group

25 eyes with refractory non infective corneal ulcer were subjected to daily insertion of a NTX film in the lower conjunctival fornix for 2 weeks

Intervention: Naltrexone Hydrochloride

Control

25 eyes with refractory non infective corneal ulcer were treated by carboxymethyl cellulose sodium 0.5 % eye drops

Intervention: Carboxy methyl cellulose

Outcomes

Primary Outcomes

healing of ulcer

Time Frame: 2 weeks

healing of ulcer measured in millemeters by clinical examination on slit lamp after staining with sodium fluorescein stain

Study Sites (1)

Loading locations...

Similar Trials